Physician/Clinic

NeuraMetrix solution provides Clinicians with a much more precise and accurate digital biomarker
to ​​​​​​​detect and monitor Neurological diseases and Psychiatric disorders
Physician discussing treatment options with patient

The gap

The neurologists/psychiatrists lack a tool to:
  • Detect symptoms at an early stage of the disease
  • Diagnose patients before the disease has permanently damaged the brain 
  • Feed them data on their patients in the long periods between the infrequent visits
  • See the effectiveness of changes in disease and rehabilitation management
  • Managing on/off periods for patients with movement disorders
  • See changes in the state of the patient or stage of the disease

The NeuraMetrix highly precise and easy to implement digital biomarker fills an important gap long sought after by Physicians and Clinics

With the easy-to-use NeuraMetrix digital biomarker, Neurologists and Psychiatrists can:
  • Continuously assess  the state of the patient and conclude if the patient is:
    • Stable  - Visit is not needed
    • Somewhat unstable – Use frequent virtual meetings as the primary interaction resulting in much better management of the disease
    • Very unstable – Meet with the patient at the clinic for further examination
  • Monitor the effect of an individualized treatment change by accessing the patient’s chart a few weeks later and determining if the changes had desired effect, no effect, or, at worse, adverse effects
  • Manage movement disorder patients who are struggling with on/off periods
  • Get a warning when a bipolar patient transitions from one state to another
  • Have more frequent interaction with their patients through convenient methods such as virtual meetings, phone, email, etc.
This enables Neurologists and Psychiatrists to
  • Productively communicate regularly between visits with their patients
  • Take immediate corrective action, if necessary
  • Tailor the treatment to the state of the disease​​​​​​​
Resulting in:
  • Improved patient outcomes
  • Better and frequent management of the disease at a lower cost
  • Better use of Neurologists' and Psychiatrists' time
//

"'We need digital biomarker technologies with very strong statistics so we can actually think about not waiting till we are so sick, we need a doctor…."


- Dr. Rhoda, Au PhD
Professor, Boston University, co-PI, Framingham Heart Study Brain Aging Project & Director of Neuropsychology, Director of Global Cohort Development, Davos Alzheimer's Collaborative
​​​​​​​​​​​​​​​​​​​​​
//

"This will revolutionize how we treat these poor patients."


- CTO of major hospital system in Scandinavia
​​​​​​​
//

"'Digital is the new blood."


- Dr. Rhoda Au, Ph.D.
Professor, Boston University, co-PI, Framingham Heart Study Brain Aging Project & Director of Neuropsychology, Director of Global Cohort Development, Davos Alzheimer's Collaborative
​​​​​​​